Linc AB (OSTO:LINC) Accumulated Depreciation : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Linc AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Linc AB Accumulated Depreciation Historical Data

The historical data trend for Linc AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Linc AB Accumulated Depreciation Chart

Linc AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

Linc AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-	-

Linc AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Linc AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Linc AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Linc AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Linc AB (OSTO:LINC) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strandvagen 7A, Stockholm, SWE, 114 51

Website

https://www.linc.se

Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invests in and develops small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.